Biomendi S.A.U.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain (NCT02254525) | Biomendi S.A.U. | 2012-05-01 |
Track Biomendi S.A.U. automatically
Every clearance here is in the API, with alerts when new ones post.